Novo Nordisk A/S has been informed that a securities lawsuit has been filed against the company in Denmark. The lawsuit is filed by a number of shareholders. The claim is
Nordic Life Science
NLS News
Novo Nordisk A/S has been informed that a securities lawsuit has been filed against the company in Denmark. The lawsuit is filed by a number of shareholders. The claim is
Swedish Orphan Biovitrum has entered into an agreement to sell a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) to AstraZeneca for a total cash consideration of USD
Alligator Bioscience has announced that a license agreement has been reached with Biotheus, a privately held Chinese company based in Zhuhai, Guangdong, China. Under the license agreement, Alligator has granted
The bioink company has entered an agreement with the owners of Cytena to acquire all its shares for a purchase price of 30.25M euros. Through cytena’s complementary technology offering, Cellink
The company has appointed Anja Peters Ohlsson as new CFO of LIDDS AB and member of the management team. Anja will succeed Bengt Norvik, who will leave his position in
Researchers at Karolinska Institutet in Sweden have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts. Pain causes suffering and
The e-health company has appointed Anki Malmborg Hager as their new CEO. PainDrainer has since 2018 developed a web-based application for self-management of chronic pain improving the quality of life
Elypta, Pilloxa and Sigrid Therapeutics have been announced as finalists in this year’s Medtech Insight Awards, an award that celebrates and recognizes excellence among the companies, teams, and individuals driving
Drug and device development
AstraZeneca and MSD have announced positive results from the Phase III PAOLA-1 trial in women with advanced ovarian cancer. The trial, in the 1st-line maintenance setting, compared Lynparza(olaparib) added to
The company has announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met theprimary composite endpoint with a statistically-significant and clinically-meaningful reduction of cardiovascular
The company has announced positive overall survival (OS) results from the Phase III FLAURA trial, a randomized, double-blinded, multi-centre trial of Tagrisso (osimertinib) in previously-untreated patients with locally-advanced or metastatic
The company announced that clinical responses were observed in 3 out of 9 patients in part 1 of the ONCOS-102 and Keytruda combination trial in anti-PD1 checkpoint inhibitor (CPI) refractory
The company has completed a planned 12 week interim analysis in the its Phase 2 proof-of-concept study of its bispecific molecule ABY-035 for moderate-to-severe psoriasis (“AFFIRM 35”). “Our Phase 2
Pharmaceutical waste
Pharmaceuticals in the environment is a growing problem of global concern. Drugs taken by humans and animals find their way into rivers, lakes and even drinking water and can have
IVL Swedish Environmental Research Institute and Simrishamn Municipality have tested a completley new treatment system that has now been added to the Stengården sewage plant in Simrishamn, Sweden. “Removing pharmaceutical
Nordic efforts to prevent pharmaceuticals affecting the environment include Danish management of hospital wastewater and a Swedish large-scale sewage plant for removal of pharmaceutical residues. Wastewater from hospitals can contain
“Removing pharmaceutical residues from the water means great environmental advantages. If we succeed we will have an innovative export product which can benefit the environment around the world.”
STAFFAN FILIPSSON, IVL
The Nobel Prize
Professor Honjo did not set out to find a cure for cancer but he is glad he did not give up and believes cancer immunotherapy will be the Number One
When your passion and lifelong work are the same. Great things can happen. Just ask James Allison.
The 2018 Nobel Prize in Medicine was awarded to James P. Allison and Tasuku Honjo for ther pioneering work in cancer immunotheraphy.
“Immunotherapy can be combined with almost anything; you can combine it with chemotherapy or radiation as long as you do it right. The benefits of immunotherapy are several; the best one is that once T cells see something different about the cancer cell and attack the cancer, they can be re-activated [if the cancer reoccurs.]” – James Allison
Upcoming events
This year’s NLSDays will take place at Malmömässan and the aim is to have a broad Nordic participation, where all countries are well represented. Jonas Ekstrand, Director General at SwedenBIO,
A place for startups, established biotech and entrepreneurs to search for finance, pharma and development partners. This event states that it highlights innovation and promotes new business relationships by bringing
This 14th edition of the event will, as always, showcase seminars, one-to-one meetings, exhibitions and lots of networking opportunities. The event which gathers more than 500 representatives from the industry,
InnoHEALTH 2019 is the fourth in the series of InnoHEALTH annual conference, building on the success of previous InnoHEALTH conferences which saw over 1500 participants from over 19 countries. The conference
In a new job
Gitte Aabo will step down as President and CEO after 27 years in the company, and 11 of these as CEO, and the Board of Directors has appointed Catherine Mazzacco
The Board of the national non-profit association for the life science industry in Sweden, SwedenBIO, has appointed Helena Strigård as their new CEO. Strigård will start her new position on
Lena Söderström, who was previously in charge at Senzime, is the new chairman of the board of directors of the Umeå-based company Inficure Bio. Lena Söderström has worked in the
Careers
In his job as Project Director at AstraZeneca’s Pharmaceutical Development unit, Anders Holmén constantly has to be one step ahead and has to be able to see how science best
Our region is filled with life science activity. We take a closer look at what´s going in our Nordic cities when it comes to life science efforts, progress and challenges.
In focus – Nordic cities
Nordic Life Science
The latest clinical trials
The company has announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met theprimary composite endpoint with a statistically-significant and clinically-meaningful reduction of cardiovascular
The company has announced positive overall survival (OS) results from the Phase III FLAURA trial, a randomized, double-blinded, multi-centre trial of Tagrisso (osimertinib) in previously-untreated patients with locally-advanced or metastatic
The company announced that clinical responses were observed in 3 out of 9 patients in part 1 of the ONCOS-102 and Keytruda combination trial in anti-PD1 checkpoint inhibitor (CPI) refractory
The company has completed a planned 12 week interim analysis in the its Phase 2 proof-of-concept study of its bispecific molecule ABY-035 for moderate-to-severe psoriasis (“AFFIRM 35”). “Our Phase 2
The company announces that the final patient has been enrolled in the LYMRIT 37-05 clinical trial of Betalutin (177Lu-satetraxetan-lilotomab) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) not eligible
AstraZeneca and MSD have announced positive results from the Phase III PAOLA-1 trial in women with advanced ovarian cancer. The trial, in the 1st-line maintenance setting, compared Lynparza(olaparib) added to
Targovax starts expansion part in the phase I/II trial with ONCOS-102 in combination with durvalumab
All safety reviews during the dose escalation phase have been completed with no Dose Limiting Toxicities (DLT) reported and the five US hospital sites are now open for further recruitment.
The company has announced that all patients have completed treatment with SiPore15 in the STAR Trial Development is well on track and top-line data will be reported in October this
The company has announced positive overall survival (OS) results from the Phase III CASPIAN trial with Imfinzi in 1st-line extensive-stage small cell lung cancer (SCLC). A planned interim analysis conducted
The latest research news from the Nordic region
Science Article
Researchers at Karolinska Institutet in Sweden have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts. Pain causes suffering and
The TEDDY study – which includes kids in Finland and Sweden – is finding factors that influence type 1 diabetes. Type 1 diabetes (T1D), which is often diagnosed in childhood,
Scientists at Washington University School of Medicine and Umeå University have found a molecular compound that prevents and even reverses resistance to the most widely used antibiotic for treating tuberculosis
Radforsk, the Radium Hospital Research Foundation, is awarding several NOK 4.5 million to new research that fights cancer with light, reports Elisabeth Kirkeng Andersen, Oslo Cancer Cluster. Radforsk is an evergreen
Immunotherapy is the 2016 Clinical Cancer Advance of the Year and a promising new strategy for treating cancer. But how far have we come? The American Society of Clinical Oncology
We asked the new Minister about her goals and efforts when it comes to the country’s life science industry and Sweden’s status as an innovation and scientific research nation. How